Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Acquires Crystalline Technology Through $230 Mil. TransForm Buy

Executive Summary

Johnson & Johnson will have access to all of TransForm Pharmaceuticals' proprietary crystalline formulation technology through its proposed $230 mil. acquisition of the privately held company

You may also be interested in...



J&J TransForm acquisition (correction)

Johnson & Johnson's purchase price for TransForm Pharmaceuticals is $230 mil.; the March 14, 2005 1issue of "The Pink Sheet" mis-stated the figure...

J&J TransForm acquisition (correction)

Johnson & Johnson's purchase price for TransForm Pharmaceuticals is $230 mil.; the March 14, 2005 1issue of "The Pink Sheet" mis-stated the figure...

J&J Open To Large-Scale Mergers; Still Prefers Centocor, Alza-Sized Deals

Johnson & Johnson is open to deals larger than the $10.5 bil. Alza acquisition, CEO William Weldon said Jan. 20

Topics

UsernamePublicRestriction

Register

PS122308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel